Platelet Transfusion in Perioperative Medicine

Seminars in Thrombosis and Hemostasis

Volumn 46, Issue 1, 2020, Pages 50-61

  Thiele, Thomas ^a   Greinacher, Andreas ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

antiplatelet therapy; perioperative; platelet; thrombocytopenia; transfusion

Indexed keywords

ANTITHROMBOCYTIC AGENT; THROMBOCYTE CONCENTRATE;

ADVERSE OUTCOME; ARTICLE; BLOOD TRANSFUSION REACTION; BRAIN HEMORRHAGE; CRITICALLY ILL PATIENT; DUAL ANTIPLATELET THERAPY; HEART SURGERY; HUMAN; LIVER SURGERY; PERIOPERATIVE MEDICINE; PHARMACOKINETIC PARAMETERS; PLATELET COUNT; POINT OF CARE TESTING; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SURGICAL PATIENT; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM; CLINICAL DECISION MAKING; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; SURGERY;

BLOOD LOSS, SURGICAL; CLINICAL DECISION-MAKING; HUMANS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET TRANSFUSION; SURGICAL PROCEDURES, OPERATIVE;

EID: 85079019912     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0039-1697951     Document Type: Article

References (136)

1. Levy J. H. Neal M. D. Herman J. H. Bacterial contamination of platelets for transfusion: strategies for prevention. Crit Care: 2018; 22 01 271
2. Devine D. V. Schubert P. Pathogen inactivation technologies: the advent of pathogen-reduced blood components to reduce blood safety risk. Hematol Oncol Clin North Am: 2016; 30 03 609 617
3. Burkhart J. M. Gambaryan S. Watson S. P., et al. What can proteomics tell us about platelets? Circ Res: 2014; 114 07 1204 1219
4. Sut C. Tariket S. Aubron C., et al. The non-hemostatic aspects of transfused platelets. Front Med (Lausanne): 2018; 5 42
5. Handtke S. Steil L. Greinacher A. Thiele T. Toward the relevance of platelet subpopulations for transfusion medicine. Front Med (Lausanne): 2018; 5 17
6. Handtke S. Steil L. Palankar R., et al. Role of platelet size revisited-function and protein composition of large and small platelets. Thromb Haemost: 2019; 119 03 407 420
7. Curley A. Stanworth S. J. Willoughby K., et al. PlaNeT2 MATISSE Collaborators. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med: 2019; 380 03 242 251
8. Baharoglu M. I. Cordonnier C. Salman R. A., et al. PATCH Investigators. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet: 2016; 387 (10038): 2605 2613
9. Estcourt L. J. Birchall J. Allard S., et al. British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. Br J Haematol: 2017; 176 03 365 394
10. Kaufman R. M. Djulbegovic B. Gernsheimer T., et al. AABB. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med: 2015; 162 03 205 213
11. Nahirniak S. Slichter S. J. Tanael S., et al. International Collaboration for Transfusion Medicine Guidelines. Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia. Transfus Med Rev: 2015; 29 01 3 13
12. Schiffer C. A. Bohlke K. Delaney M., et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol: 2018; 36 03 283 299
13. Thiele T. Selleng K. Selleng S. Greinacher A. Bakchoul T. Thrombocytopenia in the intensive care unit-diagnostic approach and management. Semin Hematol: 2013; 50 03 239 250
14. Grozovsky R. Begonja A. J. Liu K., et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med: 2015; 21 01 47 54
15. Li R. Hoffmeister K. M. Falet H. Glycans and the platelet life cycle. Platelets: 2016; 27 06 505 511
16. Arnold D. M. Lim W. A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patient. Semin Hematol: 2011; 48 04 251 258
17. Weil I. A. Kumar P. Seicean S. Neuhauser D. Seicean A. Platelet count abnormalities and peri-operative outcomes in adults undergoing elective, non-cardiac surgery. PLoS One: 2019; 14 02 e0212191
18. Hui P. Cook D. J. Lim W. Fraser G. A. Arnold D. M. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest: 2011; 139 02 271 278
19. Nijsten M. W. ten Duis H. J. Zijlstra J. G., et al. Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med: 2000; 28 12 3843 3846
20. Lubenow N. Hinz P. Thomaschewski S., et al. The severity of trauma determines the immune response to PF4/heparin and the frequency of heparin-induced thrombocytopenia. Blood: 2010; 115 09 1797 1803
21. Greinacher A. Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood: 2016; 128 26 3032 3042
22. Greinacher A. Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology (AmSoc Hematol Educ Program): 2010; 2010 135 143
23. Warkentin T. E. Levine M. N. Hirsh J., et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med: 1995; 332 20 1330 1335
24. Pouplard C. May M. A. Iochmann S., et al. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation: 1999; 99 19 2530 2536
25. Selleng S. Malowsky B. Strobel U., et al. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost: 2010; 8 01 30 36
26. Greinacher A. Warkentin T. E. Acquired non-immune thrombocytopenia. In: Marder V. J. Aird W. C. Bennett J. S., eds., Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 6 ed. Philadelphia, PA Lippincott Williams & Wilkins: 2013
27. Hiippala S. T. Myllylä G. J. Vahtera E. M. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg: 1995; 81 02 360 365
28. Rossaint R. Bouillon B. Cerny V., et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care: 2016; 20 100
29. Spahn D. R. Bouillon B. Cerny V., et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care: 2013; 17 02 R76
30. Hayward C. P. Diagnostic evaluation of platelet function disorders. Blood Rev: 2011; 25 04 169 173
31. Schnabel R. B. Wilde S. Wild P. S. Munzel T. Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int: 2012; 109 16 293 299
32. Koscielny J. Ziemer S. Radtke H., et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost: 2004; 10 03 195 204
33. Chee Y. L. Crawford J. C. Watson H. G. Greaves M.; British Committee for Standards in Haematology. Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. Br J Haematol: 2008; 140 05 496 504
34. Casari C. Bergmeier W. Acquired platelet disorders. Thromb Res: 2016; 141 02 S73 S75
35. Lukito P. Wong A. Jing J., et al. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI. J Thromb Haemost: 2016; 14 11 2253 2260
36. Hamzeh-Cognasse H. Damien P. Chabert A. Pozzetto B. Cognasse F. Garraud O. Platelets and infections-complex interactions with bacteria. Front Immunol: 2015; 6 82
37. Thiele T. Alt-Mayer T. Greinacher A. Bux J. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis. Vox Sang: 2016; 111 04 350 356
38. Thiele T. Heddle N. Greinacher A. Donor exposures in recipients of pooled platelet concentrates. N Engl J Med: 2013; 368 05 487 489
39. Tynngård N. Preparation, storage and quality control of platelet concentrates. Transfus Apheresis Sci: 2009; 41 02 97 104
40. Vassallo R. R. Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol: 2006; 13 05 323 330
41. Jutzi M. Mansouri Taleghani B. Rueesch M. Amsler L. Buser A. Nationwide implementation of pathogen inactivation for all platelet concentrates in Switzerland. Transfus Med Hemother: 2018; 45 03 151 156
42. Prudent M. D'Alessandro A. Cazenave J. P., et al. Proteome changes in platelets after pathogen inactivation - an interlaboratory consensus. Transfus Med Rev: 2014; 28 02 72 83
43. Estcourt L. J. Malouf R. Hopewell S., et al. Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev: 2017; 7 CD009072
44. Slichter S. J. Kaufman R. M. Assmann S. F., et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med: 2010; 362 07 600 613
45. Aubron C. Flint A. WJ. Ozier Y. McQuilten Z. Platelet storage duration and its clinical and transfusion outcomes: a systematic review. Crit Care: 2018; 22 01 185
46. Marini I. Aurich K. Jouni R., et al. Cold storage of platelets in additive solution: the impact of residual plasma in apheresis platelet concentrates. Haematologica: 2019; 104 01 207 214
47. Noorman F. van Dongen T. T. Plat M. J. Badloe J. F. Hess J. R. Hoencamp R. Transfusion:-80°C frozen blood products are safe and effective in military casualty care. PLoS One: 2016; 11 12 e0168401
48. Johnson L. Tan S. Wood B. Davis A. Marks D. C. Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions. Transfusion: 2016; 56 07 1807 1818
49. Michael Fitzpatrick G. Novel platelet products under development for the treatment of thrombocytopenia or acute hemorrhage. Transfus Apheresis Sci: 2019; 58 01 7 11
50. Kelly K. Dumont L. J. Frozen platelets. Transfus Apheresis Sci: 2019; 58 01 23 29
51. Marks D. C. Cryopreserved platelets: are we there yet? Transfusion: 2018; 58 09 2092 2094
52. Slichter S. J. Dumont L. J. Cancelas J. A., et al. Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopenia. Transfusion: 2018; 58 09 2129 2138
53. Magron A. Laugier J. Provost P. Boilard E. Pathogen reduction technologies: The pros and cons for platelet transfusion. Platelets: 2018; 29 01 2 8
54. Nurden A. T. Acquired antibodies to alphaIIbbeta3 in Glanzmann thrombasthenia: from transfusion and pregnancy to bone marrow transplants and beyond. Transfus Med Rev: 2018;; doi: 10.1016/j.tmrv.2018.05.002. [Epub ahead of print]
55. Balduini C. L. Melazzini F. Pecci A. Inherited thrombocytopenias-recent advances in clinical and molecular aspects. Platelets: 2017; 28 01 3 13
56. Pecci A. Diagnosis and treatment of inherited thrombocytopenias. Clin Genet: 2016; 89 02 141 153
57. Daly P. A. Schiffer C. A. Aisner J. Wiernik P. H. Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA: 1980; 243 05 435 438
58. Murphy M. F. Waters A. H. Platelet transfusions: the problem of refractoriness. Blood Rev: 1990; 4 01 16 24
59. Goel R. Ness P. M. Takemoto C. M. Krishnamurti L. King K. E. Tobian A. A. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood: 2015; 125 09 1470 1476
60. van Hout F. MA. van der Meer P. F. Wiersum-Osselton J. C., et al. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison. Transfusion: 2018; 58 04 1021 1027
61. Cohn C. S. Stubbs J. Schwartz J., et al. A comparison of adverse reaction rates for PAS C versus plasma platelet units. Transfusion: 2014; 54 08 1927 1934
62. Warkentin T. E. Morin P. A. Heddle N. M. Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA. Transfusion: 2018; 58 10 2320 2325
63. Cohen R. Escorcia A. Tasmin F., et al. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions. Transfusion: 2017; 57 07 1674 1683
64. Heddle N. M. Klama L. Singer J., et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med: 1994; 331 10 625 628
65. Roubinian N. TACO and TRALI: biology, risk factors, and prevention strategies. Hematology (Am Soc Hematol Educ Program): 2018; 2018 01 585 594
66. Clifford L. Jia Q. Subramanian A. Yadav H. Schroeder D. R. Kor D. J. Risk factors and clinical outcomes associated with perioperative transfusion-associated circulatory overload. Anesthesiology: 2017; 126 03 409 418
67. Kopko P. M. Bux J. Toy P. Antibodies associated with TRALI: differences in clinical relevance. Transfusion: 2019; 59 03 1147 1151
68. Williamson L. M. Stainsby D. Jones H., et al. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion: 2007; 47 08 1455 1467
69. Cook D. J. Crowther M. A. Meade M. O. Douketis J.; VTE in the ICU Workshop Participants. Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care: 2005; 20 04 309 313
70. Schmidt A. E. Henrichs K. F. Kirkley S. A. Refaai M. A. Blumberg N. Prophylactic preprocedure platelet transfusion is associated with increased risk of thrombosis and mortality. Am J Clin Pathol: 2017; 149 01 87 94
71. Cook D. Crowther M. Meade M., et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med: 2005; 33 07 1565 1571
72. van Hout F. M. Hogervorst E. K. Rosseel P. M., et al. Does a platelet transfusion independently affect bleeding and adverse outcomes in cardiac surgery? Anesthesiology: 2017; 126 03 441 449
73. Baschin M. Selleng S. Hummel A., et al. Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study. J Thromb Haemost: 2018; 16 04 709 717
74. Uhl L. Assmann S. F. Hamza T. H. Harrison R. W. Gernsheimer T. Slichter S. J. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood: 2017; 130 10 1247 1258
75. Wandt H. Schaefer-Eckart K. Wendelin K., et al. Study Alliance Leukemia. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet: 2012; 380 (9850): 1309 1316
76. Stanworth S. J. Estcourt L. J. Powter G., et al. TOPPS Investigators. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med: 2013; 368 19 1771 1780
77. Estcourt L. J. Stanworth S. J. Doree C. Hopewell S. Trivella M. Murphy M. F. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev: 2015; 11 CD010983
78. Vanderschueren S. De Weerdt A. Malbrain M., et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med: 2000; 28 06 1871 1876
79. Strauss R. Wehler M. Mehler K. Kreutzer D. Koebnick C. Hahn E. G. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med: 2002; 30 08 1765 1771
80. Nammas W. Dalen M. Rosato S., et al. Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting. Platelets: 2019; 30 04 480 486
81. Nascimbene A. Neelamegham S. Frazier O. H. Moake J. L. Dong J. F. Acquired von Willebrand syndrome associated with left ventricular assist device. Blood: 2016; 127 25 3133 3141
82. Estcourt L. J. Malouf R. Doree C. Trivella M. Hopewell S. Birchall J. Prophylactic platelet transfusions prior to surgery for people with a low platelet count. Cochrane Database Syst Rev: 2018; 9 CD012779
83. Estcourt L. J. Desborough M. Hopewell S. Doree C. Stanworth S. J. Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. Cochrane Database Syst Rev: 2015; 12 CD011771
84. Li D. Glor T. Jones G. A. Thrombocytopenia and neurosurgery: a literature review. World Neurosurg: 2017; 106 277 280
85. Stanworth S. J. Walsh T. S. Prescott R. J., et al. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion: 2012
86. Bilgin Y. M. van de Watering L. M. Versteegh M. I. van Oers M. H. Vamvakas E. C. Brand A. Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery. Transfusion: 2011; 51 12 2603 2610
87. Lieberman L. Bercovitz R. S. Sholapur N. S. Heddle N. M. Stanworth S. J. Arnold D. M. Platelet transfusions for critically ill patients with thrombocytopenia. Blood: 2014; 123 08 1146 1151, quiz 1280
88. Fogarty Mack P. Intracranial haemorrhage: therapeutic interventions and anaesthetic management. Br J Anaesth: 2014; 113 02 ii17 ii25
89. Roffi M. Patrono C. Collet J-P., et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J: 2016; 37 03 267 315
90. Tendera M. Aboyans V. Bartelink M. L., et al. European Stroke Organisation; ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J: 2011; 32 22 2851 2906
91. Rothwell P. M. Algra A. Chen Z. Diener H. C. Norrving B. Mehta Z. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet: 2016; 388 (10042): 365 375
92. Morrow D. A. Braunwald E. Bonaca M. P., et al. TRA 2P-TIMI 50 Steering Committee and Investigators. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med: 2012; 366 15 1404 1413
93. García Rodríguez L. A. Martín-Pérez M. Hennekens C. H. Rothwell P. M. Lanas A. Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies. PLoS One: 2016; 11 08 e0160046
94. Li L. Geraghty O. C. Mehta Z. Rothwell P. M. Oxford Vascular S.; Oxford Vascular Study. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet: 2017; 390 (10093): 490 499
95. Hao Q. Tampi M. O'Donnell M. Foroutan F. Siemieniuk R. A. Guyatt G. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ: 2018; 363 k5108
96. Devereaux P. J. Mrkobrada M. Sessler D. I., et al. POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med: 2014; 370 16 1494 1503
97. Siller-Matula J. M. Petre A. Delle-Karth G., et al. Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care: 2017; 6 08 753 770
98. Spyropoulos A. C. Albaladejo P. Godier A., et al. Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH. J Thromb Haemost: 2013; 11 08 1593 1596
99. Thygesen K. Alpert J. S. Jaffe A. S., et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). Circulation: 2018; 138 20 e618 e651
100. Helwani M. A. Amin A. Lavigne P., et al. Etiology of acute coronary syndrome after noncardiac surgery. Anesthesiology: 2018; 128 06 1084 1091
101. Devereaux P. J. Eikelboom J. Insights into myocardial infarction after noncardiac surgery in patients with a prior coronary artery stent. Br J Anaesth: 2016; 116 05 584 586
102. Rossini R. Tarantini G. Musumeci G., et al. Italian Society of Interventional Cardiology (SICI-GISE); Italian Society for the Study of Haemostasis and Thrombosis (SISET); Italian Society of Anesthesia and Intensive Care Medicine (SIAARTI); Italian Society of Surgery (SIC); Italian Society for Cardiac Surgery (SICCH); Italian Society of Vascular and Endovascular Surgery (SICVE); Italian Society of Urology (SIU); Italian Orthopaedic Society (SIOT); Italian Society of Thoracic Surgeons (SICT); Italian Federation of Scientific Societies of Digestive System Diseases (FISMAD); Italian Society of Digestive Endoscopy (SIED); Italian Association of Hospital Gastroenterology and Digestive Endoscopy (AIGO); Italian Association of Gastroenterology and Digestive Endoscopy (SIGE); Italian Society of Maxillofacial Surgery (SICMF); Italian Society of Reconstructive Plastic Surgery and Aesthetics (SICPRE); Italian Society of Gynecology and Obstetrics (SIGO); Italian Society of Neurosurgery (SINch); Italian Association of Hospital Pulmonologist (AIPO); Italian Society of Periodontology (SIdP); Italian Society of Ophthalmology (SOI); Italian Association of Hospital Otorhinolaryngologist (AOOI); Italian Association of Hospital Surgeons (ACOI); Association of Obstetricians Gynecologists Italian Hospital (AOGOI). A multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2. JACC Cardiovasc Interv: 2018; 11 05 417 434
103. Li C. Hirsh J. Xie C. Johnston M. A. Eikelboom J. W. Reversal of the anti-platelet effects of aspirin and clopidogrel. J Thromb Haemost: 2012; 10 04 521 528
104. Zafar M. U. Santos-Gallego C. Vorchheimer D. A., et al. Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. J Thromb Haemost: 2013; 11 01 100 106
105. Godier A. Taylor G. Gaussem P. Inefficacy of platelet transfusion to reverse ticagrelor. N Engl J Med: 2015; 372 02 196 197
106. Teng R. Carlson G. F. Nylander S. Andersson T. L. Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects. J Thromb Haemost: 2016; 14 12 2342 2352
107. Martin A. C. Berndt C. Calmette L., et al. The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study. Eur J Anaesthesiol: 2016; 33 05 361 367
108. Bertling A. Fender A. C. Schüngel L., et al. Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor. J Thromb Haemost: 2018; 16 06 1089 1098
109. Kruger P. C. Hirsh J. Bhagirath V. C., et al. In vitro reversal of the anti-aggregant effect of ticagrelor using untreated platelets. Thromb Haemost: 2018; 118 11 1895 1901
110. Wang H. Qi J. Li Y., et al. Pharmacodynamics and pharmacokinetics of ticagrelor vs. clopidogrel in patients with acute coronary syndromes and chronic kidney disease. Br J Clin Pharmacol: 2018; 84 01 88 96
111. Teng R. Ticagrelor: pharmacokinetic, pharmacodynamic and pharmacogenetic profile: an update. Clin Pharmacokinet: 2015; 54 11 1125 1138
112. Zafar M. U. Smith D. A. Baber U., et al. Impact of timing on the functional recovery achieved with platelet supplementation after treatment with ticagrelor. Circ Cardiovasc Interv: 2017; 10 08 e005120
113. Neumann F. J. Sousa-Uva M. Ahlsson A., et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J: 2019; 40 02 87 165
114. Fleisher L. A. Fleischmann K. E. Auerbach A. D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation: 2014; 130 24 2215 2245
115. Chassot P. G. Delabays A. Spahn D. R. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth: 2007; 99 03 316 328
116. Thiele T. Sümnig A. Hron G., et al. Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study. J Thromb Haemost: 2012; 10 05 968 971
117. Baschin M. Selleng S. Zeden J. P., et al. Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage. Vox Sang: 2017; 112 06 535 541
118. Greinacher A. Kiefel V. Klüter H. Kroll H. Pötzsch B. Riess H.; Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie; Deutsche Gesellschaft für Thrombose-und Hämostaseforschung; Deutsche Gesellschaft für Hämatologie und Onkologie. [Recommendations for platelet transfusion by the Joint Thrombocyte Working Party of the German Societies of Transfusion Medicine and Immunohaematology (DGTI), Thrombosis and Haemostasis Research (GTH), and Haematology and Oncology (DGHO)]. Dtsch Med Wochenschr: 2006; 131 47 2675 2679
119. Stainsby D. MacLennan S. Hamilton P. J. Management of massive blood loss: a template guideline. Br J Anaesth: 2000; 85 03 487 491
120. McQuilten Z. K. Crighton G. Brunskill S., et al. Optimal dose, timing and ratio of blood products in massive transfusion: results from a systematic review. Transfus Med Rev: 2018; 32 01 6 15
121. Winearls J. Reade M. Miles H., et al. Targeted coagulation management in severe trauma: the controversies and the evidence. Anesth Analg: 2016; 123 04 910 924
122. Thomas W. Samama C. M. Greinacher A. Hunt B. J.; Subcommittee on Perioperative and Critical Care. The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital-associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH. J Thromb Haemost: 2018; 16 11 2336 2340
123. Zia A. N. Chitlur M. Rajpurkar M., et al. Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype. Haemophilia: 2015; 21 01 124 132
124. De Pietri L. Bianchini M. Montalti R., et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology: 2016; 63 02 566 573
125. Weber C. F. Görlinger K. Meininger D., et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology: 2012; 117 03 531 547
126. Görlinger K. Dirkmann D. Hanke A. A. Potential value of transfusion protocols in cardiac surgery. Curr Opin Anaesthesiol: 2013; 26 02 230 243
127. Serraino G. F. Murphy G. J. Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis. Br J Anaesth: 2017; 118 06 823 833
128. National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoelastometric point of care testing (ROTEM, TEG and Sonoclot systems). Available at: https://www.nice.org.uk/guidance/dg13/chapter/1-Recommendations. Published August 2014, last accessed March 2019)
129. Foreman P. M. Ilyas A. Mooney J. Schmalz P. GR. Walters B. C. Griessenauer C. J. Antiplatelet medication reversal strategies in operative intracranial hemorrhage: a survey of practicing neurosurgeons. World Neurosurg: 2018; 116 e649 e654
130. Ogunlade J. Wiginton J. G. IV. Ghanchi H., et al. Efficacy of platelet transfusion in the management of acute subdural hematoma. Clin Neurol Neurosurg: 2018; 174 163 166
131. Li X. Sun Z. Zhao W., et al. Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage. J Neurosurg: 2013; 118 01 94 103
132. Gulati D. Dua D. Torbey M. T. Hemostasis in intracranial hemorrhage. Front Neurol: 2017; 8 80
133. Cheng K. Y. Tsang C. P. Leung G. KK. Lui W. M. The application of point-of-care platelet function assay in guiding platelet transfusion in aspirin-users with intracranial haemorrhages. J Clin Neurosci: 2018; 55 52 56
134. Pandya U. Malik A. Messina M. Albeiruti A. R. Spalding C. Reversal of antiplatelet therapy in traumatic intracranial hemorrhage: Does timing matter? J Clin Neurosci: 2018; 50 88 92
135. French S. L. Arthur J. F. Tran H. A. Hamilton J. R. Approval of the first protease-activated receptor antagonist: rationale, development, significance, and considerations of a novel anti-platelet agent. Blood Rev: 2015; 29 03 179 189
136. Ortel T. L. Perioperative management of patients on chronic antithrombotic therapy. Blood: 2012; 120 24 4699 4705